Most recent HCS Lab-related publications
Alinezhad S. et al. (2016) Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies. PLoS One 11: e0155901.
Björk JK. et al. (2016) Heat-shock factor 2 is a suppressor of prostate cancer invasion. Oncogene 35: 1770-1784.
Robinson S. et al. (2015) Segmentation of image data from complex organotypic 3D models of cancer tissues using Markov random fields. PLoS ONE 10: e0143798.
Åkerfelt M. et al. (2015) Automated tracking of tumor-stroma morphology in microtissues identifies targets within the tumor microenvironment for therapeutic intervention. Oncotarget 6: 30035-30056.
Härmä V. et al. (2015) Optimization of Invasion-Specific effects of betulin derivatives on prostate cancer cells through lead development. PLoS One. 10: e0126111.
Hickman JA. et al. (2014) IMI PREDECT Consortium: Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro/ex vivo. Biotechnol J. 9: 1115-1128.
Härmä V. et al. (2014) Quantification of dynamic morphological drug responses in 3D organotypic cell cultures by automated image analysis. PLoS ONE 9: e96426.
Björkman M. et al. (2012) Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene 31: 3444-3456.
Härmä V. et al. (2012) Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models. Oncogene 31: 2075-2078
Garcia-Bennett A, et al. (2011) In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol. 81: 976-984.
Härmä V, et al. (2010) A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 5: e10431.